Further metabolic dysregulation was detected as an upregulation in IGFBP6 in schizophrenia and a decrease in IGF2 and IGFBP3/5/7/ALS (Fig. 2e). This evidence concerns the gene IGFBP6 and amyotrophic lateral sclerosis.